| Budget Amount *help |
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2015: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2014: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2013: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
|---|
| Outline of Final Research Achievements |
A human CGRP-expressing plasmid was constructed, and used to transfect mouse bone marrow-derived matured DC (mDC) by electroporation methods. For gene therapy, Experimental autoimmune optic neuritis (EAON) developed in 50% of mice in the CGRP-transfected group compared with 80% in the mock-transfected group, and the mean pathological score for EAON was 1 in the CGRP transfected group compared with 2 in the mock-transfected group. IL-10 production by spleen cells in the CGRP-transfected group increased independent of MOG concentration, compared with the mock-transfected group. Collected serum from the patients with anti-aquapolin-4 seropositive optic neuritis was measured the protein level using 2D-DIGE. The protein levels of AMBP and Nicolin were elevated in the serum collected from the patients with anti-aquapolin-4 seropositive optic neuritis.
|
